Consensus ESG Ratings
Member Sign In
ESG News For Sarepta Therapeutics Inc
These sites contributed news to this page:
-
Sarepta Therapeutics Announces Recipients of the 7th Annual Route 79, The Duchenne Scholarship Program, for the 2024-2025 Academic Year
– Recipients include 20 individuals living with Duchenne muscular dystrophy and five siblings of individuals living with Duchenne